期刊文献+

过表达人tRNA甲基转移酶9样蛋白KIAA1456抑制HO8910PM细胞增殖 被引量:2

Overexpression of KIAA1456 inhibits the proliferation of HO8910PM cells
下载PDF
导出
摘要 目的研究人tRNA甲基转移酶9样蛋白KIAA1456的高表达对HO8910PM细胞增殖及细胞周期的影响。方法利用PCR扩增KIAA1456编码区片段,克隆插入载体Ubi-MCS-EGFP-IRES-puromycin中,构建Ubi-KIAA1456-EGFP-puromycin(LV-KIAA1456)慢病毒表达载体;将慢病毒表达载体包装生成慢病毒颗粒并感染HO8910PM细胞,72 h后观察绿色荧光蛋白(GFP)在HO8910PM卵巢癌细胞中的表达分布情况;反转录PCR检测HO8910PM细胞中KIAA1456 mRNA水平,Western blot法检测HO8910PM细胞KIAA1456蛋白表达水平;CCK-8法检测细胞增殖活性,流式细胞术检测细胞周期。结果成功构建重组慢病毒表达载体LV-KIAA1456,慢病毒颗粒感染HO8910PM细胞后,细胞中KIAA1456的mRNA和蛋白均高表达。过表达KIAA1456的HO8910 PM细胞增殖能力明显抑制、G1期细胞明显增加。结论过表达KIAA1456显著抑制HO8910 PM卵巢癌细胞增殖,细胞周期阻滞于G1期。 Objective To investigate the effect of over-expressed KIAA1456 on the proliferation and cell cycle of HO8910PM cells. Methods KIAA1456 was amplified by PCR and inserted into lentiviral expression vector Ubi-MCS-EGFP- IRES-puromycin to construct Ubi-KIAA1456-EGFP-puromycin (LV-KIAA1456) vector. Thereafter, the lentiviral particles were packaged and used to infect HO8910PM cells. The green fluorescence protein (GFP) expression was observed at 72 hours. The expression of KIAAI456 was examined by reverse transcription PCR and Western blotting. Cell growth was detected with CCK-8 assay and cell cycles were analyzed by flow cytometry. Results Reverse transcription PCR and Western blotting showed that HO8910PM cells infected with LV-KIAA1456 vector over-expressed KIAA1456 mRNA and protein. Cell proliferation was inhibited and G1 phase cells significantly increased in HO8910PM cells overexpressing KIAA1456. Conclusion Over- expression of KIAA1456 inhibits the proliferation of HO8910PM ovarian cancer cells and arrests the cell cycle in G1 phase.
出处 《细胞与分子免疫学杂志》 CAS CSCD 北大核心 2016年第9期1183-1187,共5页 Chinese Journal of Cellular and Molecular Immunology
基金 重庆市渝中区科技计划(20150116) 重庆市妇科微创诊治特色专科项目(渝卫科教2013[46]号)
关键词 卵巢癌 HO8910PM 人tRNA甲基转移酶9样蛋白(KIAA1456) 慢病毒表达载体 ovarian cancer HO8910PM KIAA1456/hTRM9L lentiviral vector
  • 相关文献

参考文献3

二级参考文献30

  • 1Wang Z, Ahmad A, Li Y, et al. Forkhead box M1 transcription factor: a novel target for cancer therapy[ J]. Cancer Treat Rev, 2010, 36(2) : 151 -156. 被引量:1
  • 2Kwok JM, Peck B, Monteiro LJ, et al. FOXM1 confers acquired cisplatin resistance in breast cancer cells[ J]. Mol Cancer Res, 2010, 8 (1) : 24 -34. 被引量:1
  • 3Wang Z, Banerjee S, Kong D, et al. Down-regulation of Forkhead Box M1 transcription factor leads to the inhibition of invasion and an- giogenesis of pancreatic cancer cells [ J ]. Cancer Res, 2007, 67 (17) : 8293 - 8300. 被引量:1
  • 4Li Q, Zhang N, Jia Z, et al. Critical role and regulation of transcription factor FoxM1 in human gastric cancer angiogenesis and progression [J]. Cancer Res, 2009, 69(8) : 3501 -3509. 被引量:1
  • 5Gialmanidis IP, Bravou V, Amanetopoulou SG, et al. Overexpression of hedgehog pathway molecules and FOXM1 in non-small cell lung car- cinomas[J]. Lung Cancer, 2009, 66(1) : 64-74. 被引量:1
  • 6Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T) ) Method[J]. Methods, 2001, 25(4): 402-408. 被引量:1
  • 7Sumimoto H, Kawakami Y. Lentiviral vector-mediated RNAi and its use for cancer research[J]. Future Oncol, 2007, 3(6): 655-664. 被引量:1
  • 8Tashiro E, Tsuchiya A, Imoto M. Functions of cyclin D1 as an onco- gene and regulation of cyclin D1 expression [ J ]. Cancer Sci, 2007, 98 (5) : 629 - 635. 被引量:1
  • 9Zebisch A, Czernilofsky AP, Keri G, et al. Signaling through RAS- RAF-MEK-ERK: from basics to bedside [ J ]. Curr Med Chem, 2007, 14(5) : 601 -623. 被引量:1
  • 10Calvisi DF, Pinna F, Ladu S, et al. Forkhead box M1B is a determi- nant of rat susceptibility to hepatocarcinogenesis and sustains ERK activity in human HCC[J]. Gut, 2009, 58(5) : 679 -687. 被引量:1

共引文献29

同被引文献1

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部